<?xml version="1.0" encoding="UTF-8"?>
<p>Despite promising preliminary evidence, no reviews to our best knowledge have systematically summarized the effectiveness of cannabinoids or cannabino-mimetic in the treatment of PTSD. Previous literature reviewed the evidence about the eCBS as a potential target for PTSD treatment and prevention, but without following a systematic approach and focusing also on pathophysiological correlates of the disorder [
 <xref rid="B28-life-11-00214" ref-type="bibr">28</xref>,
 <xref rid="B42-life-11-00214" ref-type="bibr">42</xref>,
 <xref rid="B43-life-11-00214" ref-type="bibr">43</xref>]. In consideration of what is stated above, the present systematic review is aimed at summarizing the existent evidence on medicinal cannabinoids (e.g., THC, CBD, nabilone) in the treatment of PTSD in humans, critically analyzing and discussing both the efficacy and safety of these treatment approaches.
</p>
